Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 36301

Met-enkephalin therapy: Immunomodulation and extention of corticosteroid treatment


Štambuk, Nikola; Brinar, Vesna; Marušić-Della Marina, Branka; Štambuk, Vjera; Karaman, Ksenija; Brzović, Zdravko; Zurak, Niko; Martinić, Roko; Marotti, Tanja; Šverko, Višnja et al.
Met-enkephalin therapy: Immunomodulation and extention of corticosteroid treatment // Fundamental and Clinical Pharmacology 13 Suppl. 1 / Giudicelli, J.-F. (ur.).
Pariz: Elsevier, 1999. (poster, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 36301 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Met-enkephalin therapy: Immunomodulation and extention of corticosteroid treatment

Autori
Štambuk, Nikola ; Brinar, Vesna ; Marušić-Della Marina, Branka ; Štambuk, Vjera ; Karaman, Ksenija ; Brzović, Zdravko ; Zurak, Niko ; Martinić, Roko ; Marotti, Tanja ; Šverko, Višnja ; Rabatić, Sabina ; Svoboda Beusan, Ivna ; Mažuran, Renata ; Trbojević-Čepe, Milica ; Vikić-Topić, Dražen ; Rudolf, Maja ; Malenica, Branko ; Sučić, Zdravko ; Pokrić, Biserka

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Fundamental and Clinical Pharmacology 13 Suppl. 1 / Giudicelli, J.-F. - Pariz : Elsevier, 1999

Skup
2nd European Congres of Pharmacology

Mjesto i datum
Budimpešta, Mađarska, 03.-07.07.1999

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Met-enkephalin; therapy; immunomodulation; corticosteroid; peptid-M; Lupex

Sažetak
Objectives: Met-enkephalin is an ubiquitous pentapeptide that was recently applied in the clinical studies of different autoimmune diseases and tumors (Plotnikoff et al., Clin Immunol Immunopathol, 82:93, 1997 ; Štambuk et al., Uveitis Today, Elsevier, Amserdam, pp 319-322, 1998). Methods and Results: We present the results of Met-enkephalin therapy in 38 patients with autoimmune diseases: uveitis, Behçet's disease, allergic conjunctivitis/rhinitis, optic neuritis, multiple sclerosis, SLE/overlap syndrome, rheumatoid arthritis, Evans syndrome/haemolytic anaemia. Met-enkephalin (Peptid M, LUPEX) was administered s.c. in 2 ml of physiological saline, 0.2 - 0.3 mg/kg 5 times weekly for 4 weeks. Afterwards, the weekly dose was gradually reduced every 4 weeks till 5 mg weekly. During Met-enkephalin treatment beneficial clinical effects and significant reduction in the number and severity of relapses were followed by the modulation of serum IFN, IFN-gamma, phagocyte, NK and lymphocyte functions. The improvement of EDSS, evoked potentials, visual field, MRI and ultrasonographic findings was also observed. Conclusions: Met-enkephalin therapy ranging from 6 months to >3 years induced no toxicity or side-effects, relapses were rare, mild, and in most cases did not require additional steroid therapy, i.e. only the rise of Met-enkephalin dose was sufficient. However, the synergistic action of Met-enkephalin and corticosteroids is discussed considering the fact that it is a part of ACTH precursor molecule (Blalock, Immunol Today 15:504, 1994). It is emphasised that in severe autoimmune diseases parallel administration of Met-enkephalin and corticosteroids enables significant reduction of the steroid dose (to e.g. 2-4 mg dexamethasone daily during relapse).

Izvorni jezik
Engleski

Znanstvena područja
Kemija, Javno zdravstvo i zdravstvena zaštita, Farmacija



POVEZANOST RADA


Ustanove:
Imunološki zavod d.d.,
Institut "Ruđer Bošković", Zagreb


Citiraj ovu publikaciju:

Štambuk, Nikola; Brinar, Vesna; Marušić-Della Marina, Branka; Štambuk, Vjera; Karaman, Ksenija; Brzović, Zdravko; Zurak, Niko; Martinić, Roko; Marotti, Tanja; Šverko, Višnja et al.
Met-enkephalin therapy: Immunomodulation and extention of corticosteroid treatment // Fundamental and Clinical Pharmacology 13 Suppl. 1 / Giudicelli, J.-F. (ur.).
Pariz: Elsevier, 1999. (poster, međunarodna recenzija, sažetak, znanstveni)
Štambuk, N., Brinar, V., Marušić-Della Marina, B., Štambuk, V., Karaman, K., Brzović, Z., Zurak, N., Martinić, R., Marotti, T. & Šverko, V. (1999) Met-enkephalin therapy: Immunomodulation and extention of corticosteroid treatment. U: Giudicelli, J. (ur.)Fundamental and Clinical Pharmacology 13 Suppl. 1.
@article{article, author = {\v{S}tambuk, Nikola and Brinar, Vesna and Maru\v{s}i\'{c}-Della Marina, Branka and \v{S}tambuk, Vjera and Karaman, Ksenija and Brzovi\'{c}, Zdravko and Zurak, Niko and Martini\'{c}, Roko and Marotti, Tanja and \v{S}verko, Vi\v{s}nja and Rabati\'{c}, Sabina and Svoboda Beusan, Ivna and Ma\v{z}uran, Renata and Trbojevi\'{c}-\v{C}epe, Milica and Viki\'{c}-Topi\'{c}, Dra\v{z}en and Rudolf, Maja and Malenica, Branko and Su\v{c}i\'{c}, Zdravko and Pokri\'{c}, Biserka}, editor = {Giudicelli, J.}, year = {1999}, pages = {202s}, keywords = {Met-enkephalin, therapy, immunomodulation, corticosteroid, peptid-M, Lupex}, title = {Met-enkephalin therapy: Immunomodulation and extention of corticosteroid treatment}, keyword = {Met-enkephalin, therapy, immunomodulation, corticosteroid, peptid-M, Lupex}, publisher = {Elsevier}, publisherplace = {Budimpe\v{s}ta, Ma\djarska} }
@article{article, author = {\v{S}tambuk, Nikola and Brinar, Vesna and Maru\v{s}i\'{c}-Della Marina, Branka and \v{S}tambuk, Vjera and Karaman, Ksenija and Brzovi\'{c}, Zdravko and Zurak, Niko and Martini\'{c}, Roko and Marotti, Tanja and \v{S}verko, Vi\v{s}nja and Rabati\'{c}, Sabina and Svoboda Beusan, Ivna and Ma\v{z}uran, Renata and Trbojevi\'{c}-\v{C}epe, Milica and Viki\'{c}-Topi\'{c}, Dra\v{z}en and Rudolf, Maja and Malenica, Branko and Su\v{c}i\'{c}, Zdravko and Pokri\'{c}, Biserka}, editor = {Giudicelli, J.}, year = {1999}, pages = {202s}, keywords = {Met-enkephalin, therapy, immunomodulation, corticosteroid, peptid-M, Lupex}, title = {Met-enkephalin therapy: Immunomodulation and extention of corticosteroid treatment}, keyword = {Met-enkephalin, therapy, immunomodulation, corticosteroid, peptid-M, Lupex}, publisher = {Elsevier}, publisherplace = {Budimpe\v{s}ta, Ma\djarska} }




Contrast
Increase Font
Decrease Font
Dyslexic Font